By Ayla Ellison, James Waldron - Fierce Biotech - After a promising start to the year, the biotech IPO market picked up steam again late this summer, with notable offerings from companies like Upstream, Septerna and BioAge. But what does this mean for the sector? Is...

By Benjamin Ferrer - Nutrition Insight - Scientists and physicians with the US-based cancer research and treatment organization City of Hope are presenting new research on high-fiber dietary interventions for bone marrow and stem cell transplant patients at risk for...

by Bernice Lottering - Gene Online - Regenerative medicine, as a whole, is in a critical position to transform healthcare and confront several critical challenges that threaten its widespread adoption. High costs, complex development processes, and intricate...

by Dr Rinky Kapoor - Healthcare Radius - Exosomes, which are nanoscale extracellular vesicles derived from mesenchymal stem cells (MSCs), encapsulate a diverse array of bioactive molecules, including proteins, lipids, and nucleic acids, that facilitate intercellular...

By Neuroscience News - Researchers have found that a ketogenic diet boosts CAR T cell therapy effectiveness by enhancing tumor control and survival in mice with lymphoma. The key is beta-hydroxybutyrate (BHB), a metabolite produced during ketosis, which CAR T cells...

By Silas Inman - Cancer Network News - The ability to undergo an allogeneic hematopoietic stem cell transplant (allo-HCT), the only potentially curative therapy for patients with acute myeloid leukemia (AML), is significantly influenced by socioeconomic factors with...

By University of Copenhagen - Researchers have discovered a mechanism in our cells that is essential to energy production in the muscles. The discovery may lead to new treatment for disorders affecting the muscles, like diabetes, cancer and cardiovascular disease....

by Julia Evangelou Strait - WashU Medicine - Clinical trial indicates safety, fewer cases of life-threatening graft-versus-host disease than expected Adding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening side effect,...

By Caroline Seydel - Genetic Engineering & Biotechnology News - Parkinson’s disease is characterized by the loss of dopamine-producing neurons. The current treatment is oral levodopa, which is taken up by brain neurons and converted to dopamine. But levodopa...

By Nadine A Yehya - UCDavis Health - Funding promotes local production of CAR T-cell immunotherapy for cancer patients UC Davis Health’s Stem Cell Program has received a $500,000 grant from California health insurer Health Net to improve cancer patients’ access to...

By Margarida Maia, PhD - Parkinson's News Today - The first six Parkinson’s disease patients given the investigational stem cell-based therapy TED-A9 in a clinical trial showed safety and an easing in their symptoms over one year of follow-up, the company developing...

By Technology Networks - A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia. Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric...